Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Sanofi Pasteur MSD Limited
Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 18/05/2012
PIL GARDASIL

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 17/01/2012 and displayed until 18/05/2012
Reasons for adding or updating:
  • Change to side-effects
Updated on 18/08/2011 and displayed until 17/01/2012
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about driving or using machinery
  • Changes to therapeutic indications
Updated on 02/09/2010 and displayed until 18/08/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 09/06/2010 and displayed until 02/09/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 24/09/2009 and displayed until 09/06/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 04/08/2009 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to dosage and administration
Updated on 30/06/2009 and displayed until 04/08/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 18/06/2009 and displayed until 30/06/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 17/06/2009 and displayed until 18/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 12/03/2009 and displayed until 17/06/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/12/2008 and displayed until 12/03/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change to side-effects
  • Change to MA holder contact details
Updated on 11/11/2008 and displayed until 05/12/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 15/09/2008 and displayed until 11/11/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Changes to therapeutic indications
Updated on 08/08/2008 and displayed until 15/09/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 03/07/2008 and displayed until 08/08/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 21/05/2008 and displayed until 03/07/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 26/02/2008 and displayed until 21/05/2008
Reasons for adding or updating:
  • Change to Further Information section
Updated on 15/08/2007 and displayed until 26/02/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 12/07/2007 and displayed until 15/08/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/02/2007 and displayed until 12/07/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 17/10/2006 and displayed until 20/02/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  human papillomavirus vaccine